These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15604578)

  • 1. Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
    May M; Helke C; Nitzke T; Seehafer M; Vogler H; Hoschke B
    Urol Int; 2004; 73(4):329-36. PubMed ID: 15604578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
    Harland SJ
    Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103
    [No Abstract]   [Full Text] [Related]  

  • 7. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
    Lo RK; Johnson DE
    J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders.
    Moore MR; Garrett PR; Walton KN; Waldmann TA; McIntire RK; Vogel CL
    Surg Gynecol Obstet; 1978 Aug; 147(2):167-74. PubMed ID: 80036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer.
    Fossa SD; Mason M
    Br J Urol; 1992 Jan; 69(1):108. PubMed ID: 1371085
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
    Lange PH; Hakala TR; Fraley EE
    Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in management of testicular tumor.
    Javadpour N
    Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
    Zvara V; Hornák M; Breza J; Krídl J
    Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.